Tenaya Therapeutics (TNYA)
(Delayed Data from NSDQ)
$2.72 USD
+0.07 (2.64%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $2.73 +0.01 (0.37%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 15.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.59 |
Next Year | -1.57 |
EPS (TTM) | -1.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 5.00M | 11.50M |
# of Estimates | NA | NA | 1 | 2 |
High Estimate | NA | NA | 5.00M | 15.00M |
Low Estimate | NA | NA | 5.00M | 8.00M |
Year ago Sales | 0.00M | 0.00M | NA | 5.00M |
Year over Year Growth Est. | NA | NA | NA | 130.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.40 | -1.59 | -1.57 |
# of Estimates | 6 | 6 | 8 | 7 |
Most Recent Consensus | -0.37 | -0.33 | -1.47 | -1.57 |
High Estimate | -0.25 | -0.25 | -1.18 | -1.11 |
Low Estimate | -0.45 | -0.55 | -1.88 | -1.94 |
Year ago EPS | -0.39 | -0.40 | -1.68 | -1.59 |
Year over Year Growth Est. | 2.56% | 0.00% | 5.36% | 1.50% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.40 | -1.59 | -1.57 |
7 Days Ago | -0.38 | -0.40 | -1.59 | -1.57 |
30 Days Ago | -0.38 | -0.40 | -1.59 | -1.57 |
60 Days Ago | -0.38 | -0.40 | -1.59 | -1.57 |
90 Days Ago | -0.46 | -0.49 | -1.70 | -1.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.40 | -1.59 | -1.57 |
Zacks Consensus Estimate | -0.38 | -0.40 | -1.59 | -1.57 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.40 | -0.40 | -0.39 | NA |
Estimate | -0.40 | -0.43 | -0.45 | -0.47 | NA |
Difference | 0.06 | 0.03 | 0.05 | 0.08 | 0.06 |
Surprise | 15.00% | 6.98% | 11.11% | 17.02% | 12.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more